SG11201912233TA - Method for prediction of response to cardiovascular regeneration - Google Patents
Method for prediction of response to cardiovascular regenerationInfo
- Publication number
- SG11201912233TA SG11201912233TA SG11201912233TA SG11201912233TA SG11201912233TA SG 11201912233T A SG11201912233T A SG 11201912233TA SG 11201912233T A SG11201912233T A SG 11201912233TA SG 11201912233T A SG11201912233T A SG 11201912233TA SG 11201912233T A SG11201912233T A SG 11201912233TA
- Authority
- SG
- Singapore
- Prior art keywords
- prediction
- response
- cardiovascular regeneration
- cardiovascular
- regeneration
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/50—Fibroblast growth factors [FGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/505—Erythropoietin [EPO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/53—Colony-stimulating factor [CSF]
- G01N2333/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Ecology (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Informatics (AREA)
- Databases & Information Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Bioethics (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102017116204.6A DE102017116204A1 (de) | 2017-07-18 | 2017-07-18 | Verfahren zur Vorhersage der Antwort auf die kardiovaskuläre Regeneration |
PCT/EP2018/069307 WO2019016156A1 (en) | 2017-07-18 | 2018-07-16 | METHOD FOR PREDICTING THE RESPONSE TO CARDIOVASCULAR REGENERATION |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201912233TA true SG11201912233TA (en) | 2020-01-30 |
Family
ID=63012999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201912233TA SG11201912233TA (en) | 2017-07-18 | 2018-07-16 | Method for prediction of response to cardiovascular regeneration |
Country Status (9)
Country | Link |
---|---|
US (1) | US11714093B2 (ja) |
EP (1) | EP3655775B1 (ja) |
JP (1) | JP7403162B2 (ja) |
KR (1) | KR102535577B1 (ja) |
AU (1) | AU2018302405A1 (ja) |
CA (1) | CA3069874A1 (ja) |
DE (1) | DE102017116204A1 (ja) |
SG (1) | SG11201912233TA (ja) |
WO (1) | WO2019016156A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102018125324A1 (de) * | 2018-10-12 | 2020-04-16 | Universität Rostock | Verfahren zur Vorhersage einer Antwort auf die Therapie von Krankheiten |
DE102020205364B4 (de) * | 2020-04-28 | 2022-01-20 | Universität Rostock | Verfahren zur Überwachung des Verlaufs einer Kardiomyozyten-Transplantation und Methode zur Bestimmung, ob ein Proband für einer Kardiomyozyten-Transplantation geeignet ist |
US20230169651A1 (en) * | 2020-04-30 | 2023-06-01 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and Methods For Predicting Post-Operative Right Ventricular Failure Using Echocardiograms |
IT202100011327A1 (it) * | 2021-05-04 | 2022-11-04 | Gek S R L | Metodo prognostico |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10347436B4 (de) | 2003-10-13 | 2007-08-02 | Johann Wolfgang Goethe-Universität Frankfurt am Main | In vitro Verfahren zur Diagnose der kardiovaskulären Funktionalität von Blut-abgeleiteter zirkulierender Vorläuferzellen (BDP) |
US20090280094A1 (en) | 2006-06-07 | 2009-11-12 | The University Of Tokushima | Treatment of Ischemic Diseases Using Erythropoietin |
CA2666789C (en) | 2006-10-18 | 2016-11-22 | Yong Zhao | Embryonic-like stem cells derived from adult human peripheral blood and methods of use |
WO2009061382A2 (en) * | 2007-11-02 | 2009-05-14 | Marban Eduardo T | Cardiac stem cell and myocyte secreted paracrine factors and uses thereof |
BRPI0920069A8 (pt) * | 2008-10-30 | 2017-10-03 | Centre De Rech Public De La Sante | Biomarcadores |
AU2010251151B2 (en) | 2009-05-20 | 2015-08-20 | Cardio3 Biosciences S.A. | Pharmaceutical Composition for the Treatment of Heart Diseases |
SG10202102952YA (en) | 2010-02-25 | 2021-05-28 | Abt Holding Co | Modulation of angiogenesis |
GB201007159D0 (en) * | 2010-04-29 | 2010-06-09 | Nhs Blood & Transplant | Method for evaluating anglogenic potential |
CN101940594B (zh) | 2010-08-27 | 2013-12-04 | 上海士腾生物技术有限公司 | 用于治疗缺血性心血管疾病的制剂及其制备方法 |
TW201315479A (zh) | 2011-10-12 | 2013-04-16 | Univ Nat Cheng Kung | 可促進動脈新生之醫藥組成物、及其製備方法與應用 |
WO2013137715A1 (en) * | 2012-03-16 | 2013-09-19 | Umc Utrecht Holding B.V. | Biomarkers for adverse cardiac remodeling |
GB201223058D0 (en) | 2012-12-20 | 2013-02-06 | Cardio3 Bioscience S A | Biomarker methods and compositions |
ES2939018T3 (es) | 2014-03-26 | 2023-04-18 | Hoffmann La Roche | IGFBP7 para diagnosticar una disfunción diastólica |
-
2017
- 2017-07-18 DE DE102017116204.6A patent/DE102017116204A1/de active Granted
-
2018
- 2018-07-16 WO PCT/EP2018/069307 patent/WO2019016156A1/en unknown
- 2018-07-16 JP JP2020502119A patent/JP7403162B2/ja active Active
- 2018-07-16 CA CA3069874A patent/CA3069874A1/en not_active Abandoned
- 2018-07-16 KR KR1020207003430A patent/KR102535577B1/ko active IP Right Grant
- 2018-07-16 SG SG11201912233TA patent/SG11201912233TA/en unknown
- 2018-07-16 EP EP18745528.2A patent/EP3655775B1/en active Active
- 2018-07-16 AU AU2018302405A patent/AU2018302405A1/en not_active Abandoned
- 2018-07-16 US US16/631,756 patent/US11714093B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN110945357A (zh) | 2020-03-31 |
US20200174020A1 (en) | 2020-06-04 |
EP3655775A1 (en) | 2020-05-27 |
DE102017116204A1 (de) | 2019-01-24 |
EP3655775C0 (en) | 2023-06-07 |
JP7403162B2 (ja) | 2023-12-22 |
JP2020527710A (ja) | 2020-09-10 |
EP3655775B1 (en) | 2023-06-07 |
WO2019016156A1 (en) | 2019-01-24 |
KR102535577B1 (ko) | 2023-05-23 |
AU2018302405A1 (en) | 2020-01-16 |
US11714093B2 (en) | 2023-08-01 |
KR20200031121A (ko) | 2020-03-23 |
CA3069874A1 (en) | 2019-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1247542A1 (zh) | 用於吸煙行為的量化和預測的系統和方法 | |
HK1251689A1 (zh) | 預測模型的動態執行 | |
EP3167614A4 (en) | Method of temporal derived bi-directional motion vector for motion vector prediction | |
EP2920964A4 (en) | PROCESS OF A COLOR-TRANSFORMING INTRAPREDICATION | |
HUE048265T2 (hu) | Eljárás PD-L1 mennyiségi meghatározására | |
SG11201912233TA (en) | Method for prediction of response to cardiovascular regeneration | |
GB201521357D0 (en) | Methods for predicting response to anti-TNF therapy | |
HK1231556A1 (zh) | 確定組織放射敏感性的預測方法 | |
GB2545068B (en) | Method to reduce reactivation time of cloud based services | |
ZA201706168B (en) | Method of producing metal | |
ZA201608555B (en) | Biomarkers for response to ezh2 inhibitors | |
GB201604627D0 (en) | Improved method of FT-IMS | |
GB201522552D0 (en) | Method of improving adhesion | |
GB2554576B (en) | Method for determining nucleotide sequence by application of dynamic time warping | |
SG11201800894SA (en) | Method for parallel quantification of protein variant | |
GB201403089D0 (en) | Method of producing metal | |
GB201512602D0 (en) | Method of modelling biomarkers | |
IL239909A0 (en) | Methods for treating cardiovascular signs | |
ZA201508427B (en) | Method of connecting metal strips | |
PL3075869T3 (pl) | Sposób wytwarzania stopów żelazo - krzem - glin | |
GB2550139B (en) | Functional prediction of MSCs | |
PL3265732T3 (pl) | Sposób suszenia budowli | |
IL255320A0 (en) | A method for determining system states using an evaluation filter | |
GB201509048D0 (en) | Method of assembly | |
GB201403090D0 (en) | Method of producing metal |